1 |
Loscher, W., H. Klitgaard, R. E. Twyman, and D. Scmidt (2013) New avenues for anti-epileptic drug discovery and development. Nature Rev. Drug Discov. 12: 757-776.
DOI
|
2 |
Lason, W., M. Chlebicka, and K. Rejdak (2013) Research advances in basic mechanisms of seizures and antiepileptic drug action. Pharmacol. Rep. 65: 787-801.
DOI
|
3 |
Baraban, S. C. (2007) Emerging epilepsy models: Insight from mice, flies, worms and fish. Curr. Oin. Neurol. 20: 164-168.
DOI
ScienceOn
|
4 |
Rink, J. C. (2013) Stem cell systems and regeneration in planaria. Dev. Genes Evol. 223: 67-84.
DOI
|
5 |
Buttarelli, F. R., C. Pellicano, and F. E. Pontieri (2008) Neuropharmacology and behavior in planarians: Translation to mammals. Comp. Biochem. Physiol. Part C 147: 399-408.
|
6 |
Raffa, R. B., K. E. Finno, C. S. Tallarida, and S. M. Rawls (2010) Topiramate-antagonism of L-glutamate-induced paroxysms in planarians. Eur. J. Pharmacol. 643: 150-153.
|
7 |
Hyun, W. H. and S. R. Lee (1994) Studies on the effect of anticonvulsion and analgesic by ukgansan and ukgansangami. J. Oriental Neuropsychiatry 5: 69-79.
|
8 |
Kamei, J., S. Miyata, and M. Ohsawa (2009) Involvement of benzodiazepine system in the anxiolytic-effect of Yokukansan (Yi-gan san). Progress in Neuro-Psychopharmacol. Biol. Psychiatry 33: 1431-1437.
DOI
|
9 |
Tabuchi, M., T. Yamaguchi, S. Iizuka, S. Imamura, Y. Ikarashi, and Y. Kase (2009) Ameliorative effects of Yukukansan, a traditional Japanese medicine, on learning and non-cognitive disturbances in the Tg2576 mouse model of Alzheimer's disease. J. Ethnopharmacol. 122: 157-162.
DOI
ScienceOn
|
10 |
Kawakami, Z., H. Kanno, T. Ueki, K. Terawaki, M. Tabuchi, Y. Ikarashi, and Y. Kase (2009) Neuroprotective effects of Yokukansan, a traditional Japanese medicine, on glutamate-mediated excitotoxicity in cultured cells. Neuroscience 159: 1397-1407.
DOI
|
11 |
Vincent, P. and C. Muller (2009) Kainate receptors in epilepsy and excitotoxicity. Neuroscience 158: 309-323.
DOI
|
12 |
Passarelli, F., A. Merante, F. E. Pontieri, V. Margotta, G. Venturini, and G. Palladini (1999) Opioid-dopamine interaction in planaria: a behavioral study. Comparative Biochem. Physiol. Part C 124: 51-55.
DOI
ScienceOn
|
13 |
Rawls, S. M., T. Gomez, and R. B. Raffa (2007) An NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 52212-2). Pharmacol. Biochem. Behav. 86: 499-504.
DOI
|
14 |
Raffa, R. B., L. J. Holland, and R. J. Schulingkamp (2001) Quantitative assessment of dopamine D2 antagonist activity using invertebrate (Planaria) locomotion as a functional endpoint. J. Pharmacol. Toxicol. Methods. 45: 223-226.
DOI
|
15 |
Buttarelli, F. R., C. Pellicano, and F. E. Pontieri (2008) Neuropharmacology and behavior in planarians: Translations to mammals. Comparative Biochem. Physiol. Part C 147: 399-408.
|
16 |
Buttarelli, F. R., F. E. Pontieri, V. Margotta, and G. Palladini (2000) Acetylcholine/dopamine interactions in planaria. Comparative Biochem. Physiol. Part C 125: 225-231.
|
17 |
Rowley, N. M., K. K. Madsen, A. Schousboe, and H. S. White (2012) Glutamate and GABA synthesis, release, transport and metabolism as targets for seizure control. Neurochem. Int. 61: 546-558.
DOI
|
18 |
Ramakrishnan, L. and C. DeSaer (2011) Cabamazepine inhibits distinct chemoconvulsant-induced sezure-like activity in Dugesia tigrina. Pharmacol. Biochem. Behav. 99: 665-670.
DOI
|
19 |
Kawakami, Z., H. Kanno, Y. Ikarashi, and Y. Kase (2011) Yokukansan, a kampo medicine, protects against glutamate cytotoxicity due to oxidative stress in PC12 cells. J. Ethnopharmacol. 134: 74-81.
DOI
ScienceOn
|
20 |
Kim, K. S., G. K. Sung, and B. S. Moon (1998) An experimental study on the anti-epileptic effects of ukgansan. Kor. Intern. Med. Soc. 19: 57-72.
과학기술학회마을
|
21 |
Rawls, S. M., T. Thomas, M. Adeola, T. Patil, N. Raymondi, A. Poles, M. Loo, and R. B. Raffa (2009) Topiramate antagonizes NMDA- and AMPA-induced seizure-like activity in planarians. Pharmacol. Biochem. Behav. 93: 363-367.
DOI
|